ICSD-3. American Academy of Sleep Medicine. International classification of sleep disorders, 3rd edn. Darien: American Academy of Sleep Medicine, 2014; 2014.
Wever RA. The circadian system of man: results of experiments under temporal isolation. New York: Springer; 1979.
Boivin DB, Duffy JF, Kronauer RE, Czeisler CA. Dose–response relationships for resetting of human circadian clock by light. Nature. 1996;379(6565):540–2.
Czeisler CA, Duffy JF, Shanahan TL, Brown EN, Mitchell JF, Rimmer DW, Ronda JM, Silva EJ, Allan JS, Emens JS, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 1999;284:2177–81.
Lockley SW, Skene DJ, Arendt J, Tabandeh H, Bird AC, Defrance R. Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab. 1997;82(11):3763–70.
Leger D, Guilleminault C, Defrance R, Domont A, Paillard M. Prevalence of sleep/wake disorders in persons with blindness. Clin Sci (Lond). 1999;97(2):193–9.
Lockley SW, Skene DJ, Butler LJ, Arendt J. Sleep and activity rhythms are related to circadian phase in the blind. Sleep. 1999;22(5):616–23.
Sack RL, Lewy AJ, Blood ML, Keith LD, Nakagawa H. Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J Clin Endocrinol Metab. 1992;75(1):127–34.
Czeisler CA, Shanahan TL, Klerman EB, Martens H, Brotman DJ, Emens JS, Klein T, Rizzo JI. Suppression of melatonin secretion in some blind patients by exposure to bright light [see comments]. N Engl J Med. 1995;332(1):6–11.
Warman GR, Pawley MD, Bolton C, Cheeseman JF, Fernando AT 3rd, Arendt J, Wirz-Justice A. Circadian-related sleep disorders and sleep medication use in the New Zealand blind population: an observational prevalence survey. PLoS One. 2011;6(7):e22073.
McArthur AJ, Lewy AJ, Sack RL. Non-24-hour sleep–wake syndrome in a sighted man: circadian rhythm studies and efficacy of melatonin treatment. Sleep. 1996;19(7):544–53.
Hashimoto S, Nakamura K, Honma S, Honma K. Free-running circadian rhythm of melatonin in a sighted man despite a 24-hour sleep pattern: a non-24-hour circadian syndrome. Psychiatry Clin Neurosci. 1997;51(3):109–14.
Lockley SW, Dressman MA, Licamele L, Xiao C, Fisher DM, Flynn-Evans EE, Hull JT, Torres R, Lavedan C, Polymeropoulos MH. Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. Lancet. 2015;386(10005):1754–64.
Mishima K, Tozawa T, Satoh K, Matsumoto Y, Hishikawa Y, Okawa M. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep–waking. Biol Psychiatry. 1999;45(4):417–21.
Turner PL, Van Someren EJ, Mainster MA. The role of environmental light in sleep and health: effects of ocular aging and cataract surgery. Sleep Med Rev. 2010;14(4):269–80.
Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med. 1986;315(8):485–7.
Kitamura S, Hida A, Enomoto M, Watanabe M, Katayose Y, Nozaki K, Aritake S, Higuchi S, Moriguchi Y, Kamei Y, et al. Intrinsic circadian period of sighted patients with circadian rhythm sleep disorder, free-running type. Biol Psychiatry. 2013;73(1):63–9.
Duffy JF, Cain SW, Chang AM, Phillips AJ, Munch MY, Gronfier C, Wyatt JK, Dijk DJ, Wright KP Jr, Czeisler CA. Sex difference in the near-24-hour intrinsic period of the human circadian timing system. Proc Natl Acad Sci USA. 2011;108(Suppl 3):15602–8.
Duffy JF, Wright KP Jr. Entrainment of the human circadian system by light. J Biol Rhythms. 2005;20(4):326–38.
Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness–eveningness in human circadian rhythms. Int J Chronobiol. 1976;4(2):97–110.
Barion A, Zee PC. A clinical approach to circadian rhythm sleep disorders. Sleep Med. 2007;8(6):566–77.
Kokkoris CP, Weitzman ED, Pollak CP, Spielman AJ, Czeisler CA, Bradlow H. Long-term ambulatory temperature monitoring in a subject with a hypernychthemeral sleep–wake cycle disturbance. Sleep. 1978;1(2):177–90.
Hida A, Kitamura S, Katayose Y, Kato M, Ono H, Kadotani H, Uchiyama M, Ebisawa T, Inoue Y, Kamei Y, et al. Screening of clock gene polymorphisms demonstrates association of a PER3 polymorphism with morningness–eveningness preference and circadian rhythm sleep disorder. Sci Rep. 2014;4(6309):6309.
Baehr EK, Revelle W, Eastman CI. Individual differences in the phase and amplitude of the human circadian temperature rhythm: with an emphasis on morningness–eveningness. J Sleep Res. 2000;9(2):117–27.
Duffy JF, Dijk DJ, Hall EF, Czeisler CA. Relationship of endogenous circadian melatonin and temperature rhythms to self-reported preference for morning or evening activity in young and older people. J Investig Med. 1999;47(3):141–50.
Klerman EB, Dijk DJ, Kronauer RE, Czeisler CA. Simulations of light effects on the human circadian pacemaker: implications for assessment of intrinsic period. Am J Physiol. 1996;270:R271–82.
Duffy JF, Czeisler CA. Age-related change in the relationship between circadian period, circadian phase, and diurnal preference in humans. Neurosci Lett. 2002;318:117–20.
Duffy JF, Rimmer DW, Czeisler CA. Association of intrinsic circadian period with morningness–eveningness, usual wake time, and circadian phase. Behav Neurosci. 2001;115:895–9.
Sack RL, Brandes RW, Kendall AR, Lewy AJ. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med. 2000;343(15):1070–7.
Khalsa SB, Jewett ME, Cajochen C, Czeisler CA. A phase response curve to single bright light pulses in human subjects. J Physiol. 2003;549(Pt 3):945–52.
Lewy AJ, Sack RL. Exogenous melatonin’s phase-shifting effects on the endogenous melatonin profile in sighted humans: a brief review and critique of the literature. J Biol Rhythms. 1997;12(6):588–94.
Burgess HJ, Revell VL, Eastman CI. A three pulse phase response curve to three milligrams of melatonin in humans. J Physiol. 2008;586(2):639–47.
Uchiyama M, Shibui K, Hayakawa T, Kamei Y, Ebisawa T, Tagaya H, Okawa M, Takahashi K. Larger phase angle between sleep propensity and melatonin rhythms in sighted humans with non-24-hour sleep–wake syndrome. Sleep. 2002;25(1):83–8.
Uchiyama M, Kamei Y, Tagaya H, Takahashi K. Poor compensatory function for sleep loss in delayed sleep phase syndrome and non-24-hour sleep–wake syndrome. Sleep Biol Rhythms. 2004;2(supplement 1):s5–6.
Sharma B, Feinsilver S. Circadian rhythm sleep disorders: an update. Sleep Biol Rhythms. 2009;7:113–24.
Hoban TM, Sack RL, Lewy AJ, Miller LS, Singer CM. Entrainment of a free-running human with bright light? Chronobiol Int. 1989;6(4):347–53.
Uchiyama M, Okawa M, Ozaki S, Shirakawa S, Takahashi K. Delayed phase jumps of sleep onset in a patient with non-24-hour sleep–wake syndrome. Sleep. 1996;19(8):637–40.
Regestein QR, Monk TH. Delayed sleep phase syndrome: a review of its clinical aspects. Am J Psychiatry. 1995;152(4):602–8.
Thorpy MJ, Korman E, Spielman AJ, Glovinsky PB. Delayed sleep phase syndrome in adolescents. J Adolesc Health Care. 1988;9(1):22–7.
Hayakawa T, Uchiyama M, Kamei Y, Shibui K, Tagaya H, Asada T, Okawa M, Urata J, Takahashi K. Clinical analyses of sighted patients with non-24-hour sleep–wake syndrome: a study of 57 consecutively diagnosed cases. Sleep. 2005;28(8):945–52.
Tagaya H, Matsuno Y, Atsumi Y. A schizophrenic with non-24-hour sleep–wake syndrome. Jpn J Psychiatry Neurol. 1993;47(2):441–2.
Morinobu S, Yamashita H, Yamawaki S, Tanaka K, Ohkawa M. Obsessive–compulsive disorder with non-24-hour sleep–wake syndrome. J Clin Psychiatry. 2002;63(9):838–40.
Drennan MD, Klauber MR, Kripke DF, Goyette LM. The effects of depression and age on the Horne-Ostberg morningness–eveningness score. J Affect Disord. 1991;23(2):93–8.
Mansour HA, Monk TH, Nimgaonkar VL. Circadian genes and bipolar disorder. Ann Med. 2005;37(3):196–205.
Ahn YM, Chang J, Joo YH, Kim SC, Lee KY, Kim YS. Chronotype distribution in bipolar I disorder and schizophrenia in a Korean sample. Bipolar Disord. 2008;10(2):271–5.
Wood J, Birmaher B, Axelson D, Ehmann M, Kalas C, Monk K, Turkin S, Kupfer DJ, Brent D, Monk TH, et al. Replicable differences in preferred circadian phase between bipolar disorder patients and control individuals. Psychiatry Res. 2009;166(2–3):201–9.
Gaspar-Barba E, Calati R, Cruz-Fuentes CS, Ontiveros-Uribe MP, Natale V, De Ronchi D, Serretti A. Depressive symptomatology is influenced by chronotypes. J Affect Disord. 2009;119(1–3):100–6.
Kitamura S, Hida A, Watanabe M, Enomoto M, Aritake-Okada S, Moriguchi Y, Kamei Y, Mishima K. Evening preference is related to the incidence of depressive states independent of sleep–wake conditions. Chronobiol Int. 2010;27(9–10):1797–812.
Artioli P, Lorenzi C, Pirovano A, Serretti A, Benedetti F, Catalano M, Smeraldi E. How do genes exert their role? Period 3 gene variants and possible influences on mood disorder phenotypes. Eur Neuropsychopharmacol. 2007;17(9):587–94.
Lamont EW, Legault-Coutu D, Cermakian N, Boivin DB. The role of circadian clock genes in mental disorders. Dialogues Clin Neurosci. 2007;9(3):333–42.
McClung CA. Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther. 2007;114(2):222–32.
Barnard AR, Nolan PM. When clocks go bad: neurobehavioural consequences of disrupted circadian timing. PLoS Genet. 2008;4(5):e1000040.
Kripke DF, Nievergelt CM, Joo E, Shekhtman T, Kelsoe JR. Circadian polymorphisms associated with affective disorders. J Circadian Rhythms. 2009;7(2):2.
Mendlewicz J. Disruption of the circadian timing systems: molecular mechanisms in mood disorders. CNS Drugs. 2009;23(Suppl 2):15–26.
Archer SN, Robilliard DL, Skene DJ, Smits MG, Williams A, Arendt J, Von Schantz M. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep. 2003;26:413–5.
Katzenberg D, Young T, Finn L, Lin L, King DP, Takahashi JS, Mignot E. A CLOCK polymorphism associated with human diurnal preference. Sleep. 1998;21(6):569–76.
Mishima K, Tozawa T, Satoh K, Saitoh H, Mishima Y. The 3111T/C polymorphism of hClock is associated with evening preference and delayed sleep timing in a Japanese population sample. Am J Med Genet B Neuropsychiatr Genet. 2005;133B(1):101–4.
Nievergelt CM, Kripke DF, Barrett TB, Burg E, Remick RA, Sadovnick AD, McElroy SL, Keck PE Jr, Schork NJ, Kelsoe JR. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(3):234–41.
Mansour HA, Wood J, Logue T, Chowdari KV, Dayal M, Kupfer DJ, Monk TH, Devlin B, Nimgaonkar VL. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav. 2006;5(2):150–7.
Benedetti F, Serretti A, Colombo C, Barbini B, Lorenzi C, Campori E, Smeraldi E. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet. 2003;123B(1):23–6.
Gould TD, Manji HK. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology. 2005;30(7):1223–37.
McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, Cooper DC, Nestler EJ. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci USA. 2005;102(26):9377–81.
Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V, Chakravarty S, Peevey J, Oehrlein N, Birnbaum S, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA. 2007;104(15):6406–11.
Liu X, Uchiyama M, Shibui K, Kim K, Kudo Y, Tagaya H, Suzuki H, Okawa M. Diurnal preference, sleep habits, circadian sleep propensity and melatonin rhythm in healthy human subjects. Neurosci Lett. 2000;280(3):199–202.
Bailey SL, Heitkemper MM. Circadian rhythmicity of cortisol and body temperature: morningness–eveningness effects. Chronobiol Int. 2001;18(2):249–61.
Kerkhof GA, Van Dongen HP. Morning-type and evening-type individuals differ in the phase position of their endogenous circadian oscillator. Neurosci Lett. 1996;218(3):153–6.
Mongrain V, Lavoie S, Selmaoui B, Paquet J, Dumont M. Phase relationships between sleep–wake cycle and underlying circadian rhythms in morningness–eveningness. J Biol Rhythms. 2004;19(3):248–57.
Germain A, Kupfer DJ. Circadian rhythm disturbances in depression. Hum Psychopharmacol. 2008;23(7):571–85.
Burgess HJ, Revell VL, Molina TA, Eastman CI. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. J Clin Endocrinol Metab. 2010;95(7):3325–31.
Mundey K, Benloucif S, Harsanyi K, Dubocovich ML, Zee PC. Phase-dependent treatment of delayed sleep phase syndrome with melatonin. Sleep. 2005;28(10):1271–8.
Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, Miyamoto M. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology. 2005;48(2):301–10.
Richardson GS, Zee PC, Wang-Weigand S, Rodriguez L, Peng X. Circadian phase-shifting effects of repeated ramelteon administration in healthy adults. J Clin Sleep Med. 2008;4(5):456–61.
Kamgar-Parsi B, Wehr TA, Gillin JC. Successful treatment of human non-24-hour sleep–wake syndrome. Sleep. 1983;6(3):257–64.
Uchiyama M, Mayer G, Okawa M, Meier-Ewert K. Effects of vitamin B12 on human circadian body temperature rhythm. Neurosci Lett. 1995;192(1):1–4.